Oppenheimer & Co. Inc. Has $914,000 Stock Position in Global Medical REIT Inc. (NYSE:GMRE)

Oppenheimer & Co. Inc. grew its holdings in shares of Global Medical REIT Inc. (NYSE:GMREGet Rating) by 22.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 81,416 shares of the company’s stock after purchasing an additional 14,981 shares during the period. Oppenheimer & Co. Inc. owned about 0.12% of Global Medical REIT worth $914,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. SJS Investment Consulting Inc. acquired a new position in shares of Global Medical REIT during the 1st quarter worth approximately $25,000. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Global Medical REIT during the 1st quarter worth approximately $33,000. New York State Teachers Retirement System bought a new stake in shares of Global Medical REIT during the 1st quarter worth approximately $85,000. Versor Investments LP bought a new stake in shares of Global Medical REIT during the 2nd quarter worth approximately $113,000. Finally, Amalgamated Bank bought a new stake in shares of Global Medical REIT during the 1st quarter worth approximately $118,000. Institutional investors and hedge funds own 68.86% of the company’s stock.

Analyst Upgrades and Downgrades

GMRE has been the subject of a number of recent analyst reports. StockNews.com raised shares of Global Medical REIT from a “sell” rating to a “hold” rating in a report on Friday, November 4th. BMO Capital Markets downgraded shares of Global Medical REIT from an “outperform” rating to a “market perform” rating in a report on Thursday, October 6th. Compass Point cut their price target on shares of Global Medical REIT to $17.00 in a report on Monday, August 15th. Finally, Robert W. Baird downgraded shares of Global Medical REIT from an “outperform” rating to a “neutral” rating in a research note on Monday, October 10th. Four equities research analysts have rated the stock with a hold rating, According to data from MarketBeat, Global Medical REIT currently has a consensus rating of “Hold” and an average target price of $16.50.

Global Medical REIT Price Performance

Shares of NYSE:GMRE opened at $9.51 on Tuesday. The company has a market cap of $623.08 million, a price-to-earnings ratio of 38.04, a PEG ratio of 1.30 and a beta of 1.02. The company has a debt-to-equity ratio of 1.09, a current ratio of 0.19 and a quick ratio of 0.21. The firm has a 50 day simple moving average of $8.98 and a 200 day simple moving average of $10.92. Global Medical REIT Inc. has a one year low of $7.01 and a one year high of $18.51.

Global Medical REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 11th. Investors of record on Friday, September 23rd were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 8.83%. The ex-dividend date was Thursday, September 22nd. Global Medical REIT’s payout ratio is 336.00%.

Global Medical REIT Profile

(Get Rating)

Global Medical REIT Inc is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Recommended Stories

Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMREGet Rating).

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.